Discontinuation report SEBIVO
Report ID | 89042 |
Drug Identification Number | 02288389 |
Brand name | SEBIVO |
Common or Proper name | SEBIVO 600MG 2 X 14 |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TELBIVUDINE |
Strength(s) | 600MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 2 X 14 |
ATC code | J05AF |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2019-11-01 |
Actual discontinuation date | 2019-11-01 |
Remaining supply date | 2019-11-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Expiration date of remaining supply: April 30, 2020 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2019-11-06 | French | Compare |
v6 | 2019-11-06 | English | Compare |
v5 | 2019-09-05 | English | Compare |
v4 | 2019-07-10 | French | Compare |
v3 | 2019-07-10 | English | Compare |
v2 | 2019-07-10 | French | Compare |
v1 | 2019-07-10 | English | Compare |
Showing 1 to 7 of 7